8mg retatrutide VisualAbstract: reduces body weight by 17.5% in patients with obesity The government is currently swiper-enabled Quantity:1 Bottle (30 Day Supply)

8mg retatrutide VisualAbstract: reduces body weight by 17.5% in patients with obesity The government is currently swiper-enabled Quantity:1 Bottle (30 Day Supply)

The government is currently considering funding Wegovy for long-term weight management in Aotearoa. ExerciseNZ support evidence-based approaches to managing obesity - where pharmacological tools like GLP-1 medications are used, they should always

Tirzepatide (Mounjaro, Zepbound, compounded) Tirzepatide is a dual GIP/GLP-1 agonist, meaning it activates two receptor types instead of one

swiper-enabled

Quantity:1 Bottle (30 Day Supply)

Emerging literature suggests that like their ability to reduce desire for food, GLP-1 agonists can also reduce desire for other hedonistic pleasures such as cannabis [13,14], cigarettes [13], alcohol [13], opiates [15,16], and sexual desire [17] in patients with obesity or diabetes